跳转至内容
Merck
CN
  • Development and pharmacological characterization of a model of sleep disruption-induced hypersensitivity in the rat.

Development and pharmacological characterization of a model of sleep disruption-induced hypersensitivity in the rat.

European journal of pain (London, England) (2014-09-10)
R Wodarski, S Schuh-Hofer, D A Yurek, K A Wafford, G Gilmour, R-D Treede, J D Kennedy
摘要

Sleep disturbance is a commonly reported co-morbidity in chronic pain patients, and conversely, disruption of sleep can cause acute and long-lasting hypersensitivity to painful stimuli. The underlying mechanisms of sleep disruption-induced pain hypersensitivity are poorly understood. Confounding factors of previous studies have been the sleep disruption protocols, such as the 'pedestal over water' or 'inverted flower pot' methods, that can cause large stress responses and therefore may significantly affect pain outcome measures. Sleep disruption was induced by placing rats for 8 h in a slowly rotating cylindrical cage causing arousal via the righting reflex. Mechanical (Von Frey filaments) and thermal (Hargreaves) nociceptive thresholds were assessed, and plasma corticosterone levels were measured (mass spectroscopy). Sleep disruption-induced hypersensitivity was pharmacologically characterized with drugs relevant for pain treatment, including gabapentin (30 mg/kg and 50 mg/kg), Ica-6p (Kv7.2/7.3 potassium channel opener; 10 mg/kg), ibuprofen (30 mg/kg and 100 mg/kg) and amitriptyline (10 mg/kg). Eight hours of sleep disruption caused robust mechanical and heat hypersensitivity in the absence of a measurable change in plasma corticosterone levels. Gabapentin had no effect on reduced nociceptive thresholds. Ibuprofen attenuated mechanical thresholds, while Ica-6p and amitriptyline attenuated only reduced thermal nociceptive thresholds. These results show that acute and low-stress sleep disruption causes mechanical and heat hypersensitivity in rats. Mechanical and heat hypersensitivity exhibited differential sensitivity to pharmacological agents, thus suggesting dissociable mechanisms for those two modalities. Ultimately, this model could help identify underlying mechanisms linking sleep disruption and hypersensitivity.

材料
产品编号
品牌
产品描述

Sigma-Aldrich
甲醇, suitable for HPLC, ≥99.9%
Sigma-Aldrich
甲醇, ACS reagent, ≥99.8%
Sigma-Aldrich
乙酸乙酯, ACS reagent, ≥99.5%
Sigma-Aldrich
甲醇, suitable for HPLC, gradient grade, ≥99.9%
Sigma-Aldrich
乙酸乙酯, suitable for HPLC, ≥99.7%
Sigma-Aldrich
甲醇, HPLC Plus, ≥99.9%
Sigma-Aldrich
乙酸乙酯, HPLC Plus, for HPLC, GC, and residue analysis, 99.9%
Sigma-Aldrich
甲醇, anhydrous, 99.8%
Sigma-Aldrich
甲醇, Laboratory Reagent, ≥99.6%
Sigma-Aldrich
甲醇, suitable for HPLC, gradient grade, suitable as ACS-grade LC reagent, ≥99.9%
Sigma-Aldrich
甲醇, puriss. p.a., ACS reagent, reag. ISO, reag. Ph. Eur., ≥99.8% (GC)
Sigma-Aldrich
甲醇, ACS spectrophotometric grade, ≥99.9%
Sigma-Aldrich
甲醇, ACS reagent, ≥99.8%
Sigma-Aldrich
乙酸乙酯, puriss. p.a., ACS reagent, reag. ISO, reag. Ph. Eur., ≥99.5% (GC)
Sigma-Aldrich
乙酸乙酯, suitable for HPLC, ≥99.8%
Sigma-Aldrich
乙酸乙酯, anhydrous, 99.8%
Sigma-Aldrich
布洛芬, ≥98% (GC)
Supelco
布洛芬, Pharmaceutical Secondary Standard; Certified Reference Material
USP
木精, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
甲醇, BioReagent, ≥99.93%
Sigma-Aldrich
肾上腺酮, ≥98.5% (HPLC)
Supelco
甲醇, analytical standard
Supelco
乙酸乙酯, analytical standard
Supelco
甲醇, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
肾上腺酮, ≥92%
Sigma-Aldrich
甲醇, ACS reagent, ≥99.8%
USP
布洛芬, United States Pharmacopeia (USP) Reference Standard
Supelco
乙酸乙酯, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
甲酸, ≥95%, FCC, FG
Sigma-Aldrich
乙酸乙酯, ≥99%, FCC, FG